[Prostaglandin antagonists].
D000818:Animals; D000959:Antihypertensive Agents; D001794:Blood Pressure / Q000187:drug effects; D001980:Bronchi / Q000187:drug effects; D001993:Bronchodilator Agents / Q000494:pharmacology; D012531:Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide / Q000494:pharmacology; D004285:Dogs; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007422:Intestines / Q000187:drug effects; D007429:Intraocular Pressure / Q000187:drug effects; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D009215:Myometrium / Q000187:drug effects; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000494:pharmacology; D011121:Polyphloretin Phosphate / Q000494:pharmacology; D011448:Prostaglandin Antagonists / Q000145:classification / Q000494:pharmacology*; D051381:Rats
D000959:Antihypertensive Agents; D001993:Bronchodilator Agents; D005231:Fatty Acids, Unsaturated; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D011448:Prostaglandin Antagonists; D012531:Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; C012641:N 0164; D011121:Polyphloretin Phosphate
Anagoniści prostaglandyn.